STI Stock Trade Intelligence
MYX

MAYNE PHARMA GROUP LIMITED

Health Care · ASX:MYX
$3.21
▼ -2.73%
Market cap
$263M
Turnover
$501,102
Last price
$3.21
Day change
-2.73%
Announcements
14
Range, past year
Open 4.850 · Low 2.020 · Now 3.210 · High 7.160
Open MYX in the full dashboard →
Charts, screener, momentum and signals across every ASX-listed code.

MYX momentum and trend analysis

Our analysis
Independent analysis generated by Stock Trade Intelligence as at 2026-11-16.
Momentum quality
37/100
Wyckoff phase
Accumulation14d
Trend stage
Emerging
1 Day
-2.7%
1 Week
-1.8%
1 Month
+27.4%
1 Year
-33.8%
RSI
64
Avg daily range
4.5%

MAYNE PHARMA GROUP LIMITED scores 37 out of 100 for momentum quality, a reading rated very low confidence. The score weighs trend structure, price consistency, volume backing and how long the move has held, so a high reading means a sustained trend rather than a single large day. Its trend is currently classified as Emerging.

On the Wyckoff cycle it sits in Accumulation, where it has been for 14 trading days. The weekly timeframe reads Uptrend, which does not yet agree with the daily view.

Against the wider market it is currently outperforming and the institutional accumulation signal reads low.

What stands out
  • MACD histogram positive & rising
  • RSI in healthy zone (64)
Points to watch
  • 60d drawdown -25.1%
  • Risk rating: High
  • Composite downside risk elevated
MYX appears on this screen:
ASX stocks in Wyckoff accumulationASX momentum stocks by trend qualityASX stocks breaking outASX stocks near 52-week highs

MYX announcements

Recent price-sensitive releases.
  • 2026-11-06 Mayne Pharma to divest International segment for $55.5m Asset Disposal | Progress Report
  • 2026-10-26 Mayne Pharma reports unaudited Q1 FY27 results Periodic Reports - Other
  • 2026-10-16 MYX settles US patent litigation re Imvexxy with Teva USA Progress Report
  • 2026-10-14 Supreme Court Decision in Cosette Proceedings Trading Halt Lifted | Legal Proceedings
  • 2026-10-14 Trading Halt Trading Halt
  • 2026-09-30 MYX settles US patent litigation re Imvexxy with Sun Pharma Progress Report | Legal Proceedings
  • 2026-08-27 2026 Full Year Results Media Release Web Cast | Preliminary Final Report
Get the daily briefing The day's price-sensitive announcements, ranked by what actually moved, with our own momentum and cycle read on each.